COVID-19 SARS-CoV-2 Ag Test (In House Only)


The SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens collected from individuals suspected of COVID-19 within the first 12 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19. Used with the LumiraDx Platform the test delivers rapid results.

This assay uses SARS-CoV-2 specific antibodies in a particle-particle immunoassay to determine the presence of SARS-CoV-2 Nucleocapsid Protein (NP) antigen present in the test sample.

The LumiraDx SARS-CoV-2 Test was found not to cross-react with a panel of organisms and viruses including several human coronaviruses.